Riskpilot← Back to searchSign inGet full accessMDK HELSE AS
ASActiveOrg 926111760Risengbakken 2, 3413 LierPhysiotherapy activities · NACE 8695Est. 20202 employees
Revenue 2025
NOK 1,1M
+9% vs 2024
EBITDA margin
14.1%
+72% vs 2024
Equity ratio
60.2%
Financial strength
Net profit 2025
NOK 119K
+79% vs 2024
| Revenue | NOK 1,1M | +9% |
| EBITDA | NOK 149K | +72% |
| Net profit | NOK 119K | +79% |
| Total assets | NOK 412K | +42% |
| Equity | NOK 248K | +19% |
| Employees | 2 | — |
Legal name
MDK HELSE AS
Org number
926111760
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
5. desember 2020
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Fysioterapi-/ manuellterapi virksomhet. Selskapets formål er, som et datterselskap, være et driftsselskap under morselskapet og kan ved overskudd tildele utbytte som kan refinansieres i andre nye prosjekter inn til de korte holdning as. Eier av mdk helse as er de korte holdning as.
Address
Risengbakken 2, 3413 Lier
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 615 | 767 | 791 | 969 | 1 061 |
| Staff expenses | −348 | −415 | −449 | −552 | −499 |
| EBITDA | −87 | 59 | 56 | 87 | 149 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −87 | 59 | 56 | 87 | 149 |
| Net financials | 0 | −8 | −1 | 0 | 5 |
| Profit before tax | −87 | 52 | 55 | 87 | 154 |
| Tax | −19 | 31 | 13 | 20 | 35 |
| Net profit | −68 | 21 | 42 | 66 | 119 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 56 | 53 | 162 | 289 | 412 |
| Equity | 42 | 46 | 141 | 209 | 248 |
| Long-term debt | 0 | 0 | 0 | 0 | 2 |
| Short-term debt | 14 | 7 | 20 | 81 | 162 |
| Total debt | 14 | 7 | 20 | 81 | 164 |
EBITDA margin
14.1%
This company
15.8%
Market median
-11% vs market
20212025
Equity ratio
60.2%
This company
38.2%
Market median
+58% vs market
20212025
Return on equity
47.9%
This company
18.4%
Market median
+160% vs market
20212025
Net profit margin
11.2%
This company
8.1%
Market median
+38% vs market
20212025
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
20212025
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MD Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MDK HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mette De Korte | Chief Executive Officer | 0 companies |